Adarza Aims to Launch Biomarker Detection Platform Next Year; Adds Former Roche CEO to Board
June 03, 2011
Adarza Aims to Launch Biomarker Detection Platform Next Year; Adds Former Roche CEO to Board
The company disclosed two additions to its board of directors, including former Roche Molecular Systems CEO Heiner Dreismann, as it moves to commercialize its AIR biomarker detection platform for clinical research and diagnostic applications.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Movers & Shakers
May 27, 2011 / ProteoMonitor - Magnetic Biosensor Could Enable Simultaneous Monitoring of Thousands of Protein-Ligand Bindings
May 6, 2011 / ProteoMonitor - Shifting Focus From Dx Development, Quanterix Aims to Launch Commercial SiMoA Instrument in 2013
February 25, 2011 / ProteoMonitor - CPGR and UBC to Collaborate on Protein Biomarkers to Measure Flu Vaccine Response
June 18, 2010 / ProteoMonitor - SuppreMol to Use Protagen Biomarker Panel
August 2, 2011 / GenomeWeb Daily News